Genpharmasec Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 62.17 million compared to INR 74.39 million a year ago. Revenue was INR 62.74 million compared to INR 74.5 million a year ago. Net income was INR 10.46 million compared to INR 0.399 million a year ago. Basic earnings per share from continuing operations was INR 0.04. Diluted earnings per share from continuing operations was INR 0.04.
For the full year, sales was INR 255.16 million compared to INR 273.21 million a year ago. Revenue was INR 256.16 million compared to INR 274.13 million a year ago. Net income was INR 11.25 million compared to net loss of INR 2.09 million a year ago. Basic earnings per share from continuing operations was INR 0.04 compared to basic loss per share from continuing operations of INR 0.01 a year ago. Diluted earnings per share from continuing operations was INR 0.04 compared to diluted loss per share from continuing operations of INR 0.01 a year ago.